summari
fouchier
et
al
report
isol
genom
sequenc
novel
coronaviru
tent
name
human
betacoronaviru
hcovemc
saudi
patient
present
pneumonia
renal
failur
june
genom
sequenc
show
viru
belong
group
c
speci
genu
betacoronaviru
phylogenet
relat
bat
coronavirus
previous
found
lesser
bamboo
bat
japanes
pipistrel
bat
hong
kong
respect
anoth
patient
qatar
similar
clinic
present
posit
rtpcr
test
report
septemb
compar
contrast
clinic
present
laboratori
diagnosi
manag
infect
due
novel
coronaviru
sar
coronaviru
despit
pauciti
publish
inform
former
sinc
emerg
infecti
pathogen
came
anim
emerg
novel
viru
may
repres
anoth
instanc
interspeci
jump
betacoronaviru
anim
human
similar
group
coronaviru
possibl
bovin
sourc
group
b
sar
coronaviru
bat
civet
human
despit
appar
low
transmiss
viru
stage
research
prepared
anoth
sarslik
pandem
import
precautionari
strategi
british
infect
associ
publish
elsevi
ltd
right
reserv
world
wit
first
pandem
new
millennium
instead
anticip
influenza
viru
pandem
caus
first
time
novel
coronaviru
subsequ
name
sever
acut
respiratori
syndrom
sar
coronaviru
cov
within
month
viru
caus
total
case
sar
death
countri
among
five
contin
crude
fatal
rate
around
outbreak
left
last
impact
live
infect
also
frontlin
healthcar
worker
public
health
offici
even
gener
public
mani
slightest
hint
potenti
reemerg
sar
would
begin
anoth
nightmar
septemb
less
decad
sar
pandem
world
health
organ
report
two
case
sever
communityacquir
pneumonia
bear
signific
reminisc
sar
tabl
subsequ
laboratori
test
reveal
novel
human
coronaviru
human
betacoronaviru
hcovemc
emerg
two
case
hcovemc
infect
stage
may
repres
one
four
possibl
scenario
firstli
hcovemc
may
similar
season
human
coronaviru
detect
less
sampl
respiratori
tract
infect
gener
popul
seroposit
due
mild
asymptomat
infect
past
even
human
coronaviru
occasion
associ
mortal
underli
multipl
comorbid
present
acut
communityacquir
pneumonia
therefor
two
sever
case
hcovemc
may
repres
tip
iceberg
due
anoth
previous
unknown
season
coronaviru
secondli
may
analog
situat
avian
influenza
occasion
transmiss
viru
poultri
human
manifest
sever
diseas
mortal
thirdli
rare
instanc
isol
zoonot
infect
deadend
fourth
situat
danger
one
begin
anoth
sarslik
pandem
increas
animaltohuman
subsequ
humantohuman
transmiss
suitabl
environment
condit
opportun
transmiss
associ
laps
biosafeti
infect
control
measur
present
viru
may
caus
explos
outbreak
case
sar
would
therefor
import
review
current
knowledg
clinic
featur
epidemiolog
virolog
laboratori
diagnosi
novel
coronaviru
importantli
formul
possibl
treatment
option
infect
control
measur
base
comparison
made
coronavirus
includ
sar
cov
four
genera
famili
coronavirida
within
order
nidoviral
fig
genu
alphacoronaviru
contain
human
coronaviru
associ
common
cold
genera
gammacoronaviru
deltacoronaviru
contain
virus
affect
anim
especi
avian
speci
genu
betacoronaviru
contain
four
group
group
contain
human
coronaviru
associ
respiratori
tract
infect
group
b
contain
sarscov
associ
sever
pneumonia
hcovemc
belong
group
c
betacoronaviru
group
betacoronaviru
contain
rousettu
bat
coronaviru
member
coronavirida
known
caus
respiratori
intestin
hepat
neurolog
diseas
vari
sever
human
anim
similar
coronavirus
hcovemc
envelop
positivesens
singlestrand
rna
viru
genom
size
kb
classifi
group
coronaviru
previou
nomenclatur
name
erasmu
medic
center
rotterdam
netherland
first
institut
sequenc
viral
genom
close
relat
bat
coronavirus
found
lesser
bamboo
bat
tylonycteri
pachypu
fig
b
japanes
pipistrel
bat
pipistrellu
abramu
fig
respect
shown
phylogenet
tree
fig
expect
genom
arrang
also
similar
member
group
c
betacoronaviru
differ
group
gene
order
contain
highli
conserv
polymeras
helicas
gene
follow
highli
variabl
gene
encod
spike
five
accessori
protein
conserv
envelop
membran
nucleoprotein
fig
polymeras
gene
rdrp
hcovemc
amino
acid
ident
bat
coronavirus
spike
gene
amino
acid
ident
bat
coronavirus
environment
stabil
viru
known
stage
might
import
determin
potenti
dissemin
case
sar
cov
viru
higher
degre
stabil
environ
human
coronavirus
could
surviv
least
two
three
day
dri
surfac
room
temperatur
two
four
day
stool
studi
conduct
obtain
key
basic
virolog
inform
includ
life
cycl
molecular
evolut
order
understand
clinic
epidemiolog
signific
clinic
present
laboratoryconfirm
case
infect
associ
hcovemc
acut
sever
communityacquir
pneumonia
acut
renal
failur
tabl
case
preced
period
mild
respiratori
symptom
fever
rhinorrhoea
august
august
follow
period
clinic
stabil
august
sept
prior
reemerg
symptom
includ
cough
arthralgia
myalgia
deterior
sever
pneumonia
acut
renal
failur
current
unknown
whether
initi
mild
symptom
caus
novel
viru
relat
anoth
mild
viral
infect
microbiolog
diagnosi
made
note
friend
case
travel
trip
also
develop
initi
mild
symptom
recov
without
subsequ
deterior
remain
seen
whether
novel
coronaviru
caus
mild
infect
especi
specif
virolog
diagnost
test
perform
routin
place
limit
clinic
inform
releas
stage
clinic
present
hcovemc
infect
unusu
among
human
coronavirus
caus
predominantli
acut
selflimit
upper
respiratori
tract
infect
without
renal
failur
except
sar
cov
caus
acut
pibatcov
tybatcov
communityor
hospitalacquir
pneumonia
rapid
respiratori
deterior
besid
present
symptom
fever
chill
myalgia
malais
nonproduct
cough
clinic
deterior
typic
occur
one
week
onset
symptom
sar
usual
accompani
wateri
diarrhoea
physic
find
indiscrimin
caus
atyp
pneumonia
common
chest
radiograph
find
includ
groundglass
opac
focal
consolid
predilect
involv
peripheri
subpleur
region
lower
zone
progress
involv
bilater
lung
field
spontan
pneumomediastinum
promin
histopatholog
featur
sar
patient
die
tenth
day
symptom
onset
acut
diffus
alveolar
damag
air
space
oedema
mixtur
acut
chang
organ
phase
diffus
alveolar
damag
respect
less
commonli
haemophagocytosi
alveolar
exud
thrombosi
venul
secondari
bacteri
fungal
pneumonia
system
vascul
involv
wall
small
vein
also
report
unfortun
postmortem
histopatholog
find
case
avail
comparison
stage
unusu
clinic
featur
observ
case
infect
associ
hcovemc
presenc
acut
renal
failur
acut
renal
failur
histolog
evid
acut
tubular
necrosi
present
patient
sar
possibl
due
hypox
kidney
damag
poor
prognost
factor
howev
sar
patient
urin
viral
load
detect
quantit
revers
transcriptionpolymeras
chain
reaction
rtpcr
correl
abnorm
urinalysi
would
import
know
rel
contribut
direct
hcovemc
induc
cytolysi
indirect
pneumoniarel
hypox
damag
sever
renal
patholog
broiler
chicken
suffer
infect
avian
nephropathogen
infecti
bronchiti
viru
sever
renal
swell
accumul
urat
tubul
commonli
seen
histolog
find
includ
lymphoplasmacyt
interstiti
nephriti
characterist
tubular
epitheli
degener
slough
minim
respiratori
involv
note
nephropathogen
coronaviru
import
differenti
caus
viral
pneumonia
acut
renal
failur
consid
initi
sepsi
workup
compat
case
unrev
includ
hantavirus
agent
viral
haemorrhag
fever
influenza
virus
extrapulmonari
manifest
sar
includ
lymphopenia
diarrhoea
hepat
dysfunct
diastol
cardiac
impair
pulmonari
arteri
thrombosi
bleed
diathesi
myositi
neuromuscular
abnorm
epilept
fit
also
look
two
case
hcovemc
infect
lack
knowledg
spectrum
diseas
sever
interim
case
definit
case
find
may
appropri
notif
frontlin
clinic
manag
triag
initi
present
may
milder
form
acut
respiratori
infect
without
subsequ
deterior
tabl
elderli
young
children
sar
atyp
present
absenc
fever
respiratori
symptom
mild
form
infect
occasion
report
furthermor
coinfect
caus
agent
communityacquir
pneumonia
may
lead
fals
sens
secur
agent
acut
respiratori
diseas
found
case
sar
coinfect
human
metapneumoviru
report
patient
therefor
appli
interim
case
definit
investig
patient
without
individu
risk
assess
may
lead
signific
proport
patient
atyp
present
mild
diseas
coinfect
miss
order
better
understand
full
spectrum
clinic
featur
promptli
provid
necessari
treatment
appli
appropri
infect
control
measur
stop
dissemin
novel
coronaviru
work
algorithm
less
stringent
criteria
investig
area
resourc
avail
consid
fig
hong
kong
recommend
investig
patient
base
individu
risk
assess
approach
immunocompet
adult
patient
travel
resid
area
infect
hcovemc
report
close
contact
within
last
day
onset
ill
probabl
confirm
case
case
ill
present
fever
respiratori
symptom
receiv
baselin
chest
radiograph
assess
lower
respiratori
tract
involv
urinalysi
renal
function
test
detect
renal
impair
immunocompromis
elderli
paediatr
patient
may
atyp
mild
form
infect
decis
investig
liber
pathognomon
similar
sar
cov
posit
viral
cultur
respiratori
faecal
urin
tissu
specimen
fourfold
rise
neutral
antibodi
titr
serum
sampl
taken
day
apart
definit
evid
infect
howev
use
acut
stage
ill
limit
long
turnaround
time
absenc
access
design
biosafeti
level
laboratori
viral
cultur
need
convalesc
sampl
hcovemc
cultur
zaki
et
al
monkey
kidney
cell
vero
llcmk
cell
line
case
laboratori
diagnosi
made
nucleic
acid
detect
pancoronaviru
rtpcr
follow
viral
genom
sequenc
develop
specif
quantit
realtim
rtpcr
turnaround
time
hour
expect
soon
low
number
case
imped
valid
test
take
experi
sar
cov
diagnost
two
specif
gene
target
name
polymeras
gene
nucleoprotein
gene
consid
well
conserv
coronavirus
less
subject
variat
differ
clinic
strain
howev
use
accessori
protein
gene
sequenc
upstream
envelop
gene
e
present
hcovemc
report
highli
specif
nucleoprotein
gene
theoret
advantag
sensit
subgenom
rna
copi
number
abund
infect
cell
clinic
studi
sar
cov
definit
prove
advantag
sinc
time
peak
viral
load
hcovemc
determin
repeat
test
suspect
case
initi
neg
result
necessari
avoid
falseneg
result
viral
load
sar
cov
nasopharyng
aspir
npa
peak
day
symptom
onset
sinc
implic
posit
case
signific
posit
test
result
singl
sampl
confirm
second
test
detect
differ
region
viral
genom
sampl
order
avoid
falseposit
result
due
amplicon
carryov
two
case
present
sever
pneumonia
lower
respiratori
tract
involv
lower
tract
specimen
includ
sputum
bronchoalveolar
lavag
endotrach
aspir
even
lung
tissu
case
prefer
specimen
type
collect
put
viral
transport
medium
howev
suspect
case
upper
respiratori
tract
involv
clinic
appar
npa
nasopharyng
swab
throat
swab
andor
expector
sputum
obtain
initi
neg
repeat
deterior
symptom
day
day
symptom
onset
fig
case
sar
coronavirus
fece
urin
sera
might
use
collect
test
clinic
indic
besid
rtpcr
serum
antigen
detect
monoclon
antibodi
monospecif
polyclon
antibodi
person
posit
laboratori
confirm
infect
human
betacoronaviru
close
contact
anyon
provid
care
patient
includ
healthcar
worker
famili
member
similarli
close
physic
contact
anyon
stay
place
eg
live
visit
probabl
confirm
case
case
symptomat
close
contact
develop
symptom
within
first
day
last
contact
investig
date
ill
onset
index
case
throughout
symptomat
period
health
social
care
worker
provid
direct
care
examin
symptomat
confirm
case
within
close
vicin
aerosol
gener
procedur
feet
wear
full
ppe
time
correctli
fit
high
filtrat
mask
gown
glove
eye
protect
household
prolong
facetofac
contact
min
confirm
case
time
ill
onset
household
set
close
contact
prolong
facetofac
contact
min
confirm
case
enclos
set
wear
mask
eg
school
visitor
hospit
bed
side
ard
acut
respiratori
distress
syndrom
ppe
person
protect
equip
discoveri
hcovemc
begin
anoth
sarslik
pandem
viral
n
protein
also
shown
sensit
specif
test
serodiagnosi
sar
onset
neutral
antibodi
respons
might
also
use
infect
associ
hcovemc
especi
area
rtpcr
avail
spectrum
clinic
manifest
epidemiolog
potenti
dissemin
new
diseas
still
poorli
understood
antibodi
detect
assay
would
use
seroepidemiolog
studi
would
highli
use
determin
exact
situat
plan
relev
infect
control
strategi
contain
infect
earli
stage
inform
epidemiolog
infect
associ
hcovemc
mainli
deriv
sequenc
import
event
summar
tabl
import
epidemiolog
linkag
present
seem
travel
resid
area
infect
report
name
qatar
kingdom
saudi
arabia
preced
day
prior
onset
ill
case
histori
contact
camel
sheep
given
close
phylogenet
relationship
hcovemc
bat
coronavirus
fig
specul
wild
anim
includ
bat
may
serv
natur
reservoir
mani
group
b
c
betacoronavirus
jump
one
intermedi
host
food
game
anim
dwell
close
human
case
infect
due
sar
cov
civet
hendra
hors
nipah
swine
ebola
primat
virus
pipistrel
natur
reservoir
bat
coronaviru
found
kingdom
saudi
arabia
also
seen
mani
part
world
one
possibl
reason
case
infect
associ
hcovemc
report
area
may
explain
draw
analog
sar
cov
whose
transmiss
horsesho
bat
rhinolophu
sp
human
enhanc
intermedi
anim
host
palm
civet
raccoon
dog
hong
kong
regular
surveil
coronavirus
patient
specimen
nonbat
anim
specimen
past
year
reveal
singl
case
infect
group
c
betacoronavirus
use
consensu
coronaviru
primer
amplicon
sequenc
might
relat
absenc
necessari
intermedi
host
amplifi
novel
viru
local
high
level
biosecur
measur
adopt
farm
market
studi
requir
prove
postul
concern
animaltohuman
transmiss
contrast
sar
persontoperson
transmiss
far
observ
infect
associ
hcovemc
case
clinic
appar
infect
seen
healthcar
worker
personnel
medic
escort
compani
involv
care
transfer
patient
qatar
unit
kingdom
furthermor
two
confirm
case
separ
three
month
tempor
specif
epidemiolog
linkag
except
kingdom
saudi
arabia
prior
onset
ill
case
report
might
signifi
absenc
ongo
transmiss
commun
howev
outbreak
sever
respiratori
ill
occur
jordanian
hospit
april
involv
total
peopl
eight
healthcar
worker
one
fatal
case
subsequ
confirm
associ
hcovemc
persontoperson
transmiss
particularli
nosocomi
transmiss
would
possibl
tabl
case
sar
persontoperson
transmiss
direct
indirect
contact
mucosa
infecti
respiratori
droplet
fomit
consid
primari
mode
spread
although
airborn
transmiss
special
circumst
report
nosocomi
transmiss
facilit
use
nebul
suction
intub
bronchoscopi
cardiopulmonari
resuscit
also
well
document
importantli
unlik
influenza
patient
sar
infecti
fifth
day
onset
symptom
viral
load
nasopharyng
secret
usual
peak
tenth
day
therefor
novel
viru
truli
capabl
caus
persontoperson
spread
optim
infect
control
strategi
might
need
review
hajj
approach
recommend
whether
travel
restrict
addit
infect
control
measur
requir
urgent
need
would
disastr
phenomenon
superspread
event
observ
sar
also
encount
infect
associ
hcovemc
exampl
larg
commun
outbreak
occur
amoy
garden
hong
kong
dri
u
trap
sewag
drain
facilit
contamin
aerosol
gener
toilet
exhaust
fan
ascend
light
well
connect
differ
floor
result
massiv
outbreak
affect
hundr
resid
term
host
risk
develop
sever
diseas
conclus
could
made
present
patient
report
free
chronic
medic
condit
prior
infect
anoth
poorli
defin
characterist
infect
associ
novel
viru
incub
period
neither
case
gave
accur
account
incub
period
prior
onset
symptom
consid
sporad
case
gener
incub
period
human
nonsar
coronavirus
day
sar
cov
day
well
document
incub
period
novel
infect
critic
set
appropri
case
definit
case
find
optim
time
laboratori
test
number
test
requir
decid
necessari
period
medic
surveil
quarantin
requir
contact
confirm
case
respect
proven
effect
antivir
agent
coronavirus
includ
sar
hcovemc
anim
model
satisfi
koch
postul
test
antivir
treatment
immun
yet
report
hcovemc
clinic
manag
therefor
mainli
support
particular
emphasi
organ
support
respiratori
renal
failur
recent
advanc
made
use
extracorpor
membran
oxygen
ecmo
intens
care
unit
shown
improv
surviv
rate
case
acut
respiratori
failur
renal
failur
continu
venouseven
haemofiltr
commonli
use
intens
care
unit
aim
tide
patient
initi
critic
stage
broadspectrum
antimicrobi
coverag
typic
atyp
agent
sever
communityacquir
pneumonia
regimen
consist
blactam
macrolid
antivir
influenza
institut
await
laboratori
diagnosi
antimicrobi
treatment
stop
diagnosi
hcovemc
associ
pneumonia
made
unless
situat
nosocomi
infect
immunosuppress
state
coexist
specif
antivir
agent
includ
interferon
ribavirin
lopinavirritonavir
without
highdos
corticosteroid
use
patient
sar
use
limit
lack
evid
random
control
trial
potenti
side
effect
especi
ribavirin
steroid
mani
agent
shown
invitro
activ
sar
cov
includ
proteas
inhibitor
nelfinavir
other
angiotensinconvert
enzym
analogu
helicas
inhibitor
nucleosid
analogu
howev
invivo
activ
clinic
util
sar
coronavirus
remain
elus
corticosteroid
longer
consid
sinc
patient
sever
pneumonia
respiratori
failur
support
ecmo
till
cytokin
storm
immunomodul
therapi
igmenrich
immunoglobulin
convalesc
plasma
neutral
antibodi
use
small
number
patient
sar
data
gener
studi
limit
small
number
patient
involv
lack
random
control
trial
conduct
convalesc
plasma
rel
free
side
effect
might
consid
novel
viru
continu
caus
sever
infect
larger
number
patient
howev
convalesc
patient
prepar
convalesc
plasma
would
feasibl
current
specif
intern
guidelin
infect
control
hcovemc
recommend
strategi
discuss
interim
guidelin
infect
prevent
control
epidemicand
pandemicpron
acut
respiratori
diseas
heath
care
includ
practic
standard
contact
airborn
precaut
rout
transmiss
better
defin
hpa
unit
kingdom
recommend
similarli
stringent
approach
besid
recommend
second
virolog
test
consid
patient
deterior
day
day
symptom
onset
symptomat
contact
initi
neg
test
result
viral
load
may
peak
day
case
sar
cov
travel
restrict
impos
present
subsequ
develop
event
associ
hcovemc
must
close
monitor
especi
hajj
approach
recommend
infect
control
measur
regard
anim
contact
simpl
person
hygien
measur
hand
hygien
contact
anim
excreta
taken
one
major
reason
sar
cov
success
caus
devast
pandem
lack
anticip
global
health
commun
although
current
avail
inform
hcovemc
seem
suggest
lower
transmiss
sar
cov
mani
import
epidemiolog
clinic
scientif
question
remain
unresolv
healthcar
author
discard
potenti
novel
viru
caus
anoth
sarslik
pandem
answer
avail
overreact
unnecessari
appropri
prepar
collabor
intern
local
health
agenc
import
